These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1782524)

  • 1. The visual defect in multiple sclerosis and optic neuritis. A combined psychophysical and electrophysiological investigation.
    Russell MH; Murray IJ; Metcalfe RA; Kulikowski JJ
    Brain; 1991 Dec; 114 ( Pt 6)():2419-35. PubMed ID: 1782524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal and cortical evoked responses to chromatic contrast stimuli. Specific losses in both eyes of patients with multiple sclerosis and unilateral optic neuritis.
    Porciatti V; Sartucci F
    Brain; 1996 Jun; 119 ( Pt 3)():723-40. PubMed ID: 8673486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise.
    Flanagan P; Zele AJ
    Ophthalmic Physiol Opt; 2004 May; 24(3):225-33. PubMed ID: 15130171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equiluminant red-green and blue-yellow VEPs in multiple sclerosis.
    Sartucci F; Murri L; Orsini C; Porciatti V
    J Clin Neurophysiol; 2001 Nov; 18(6):583-91. PubMed ID: 11779973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The visual-evoked cortical potential to colour stimuli in multiple sclerosis and optic neuritis.
    Tarr KH; Hidajat RR; Goode DH
    Trans Ophthalmol Soc N Z; 1984; 36():13-5. PubMed ID: 6591605
    [No Abstract]   [Full Text] [Related]  

  • 6. Recovery of vision and pupil responses in optic neuritis and multiple sclerosis.
    Moro SI; Rodriguez-Carmona ML; Frost EC; Plant GT; Barbur JL
    Ophthalmic Physiol Opt; 2007 Sep; 27(5):451-60. PubMed ID: 17718884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colour vision abnormalities in multiple sclerosis.
    Harrison AC; Becker WJ; Stell WK
    Can J Neurol Sci; 1987 Aug; 14(3):279-85. PubMed ID: 3664369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis.
    Alshuaib WB
    Electromyogr Clin Neurophysiol; 2000 Jun; 40(4):243-52. PubMed ID: 10907603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatic, spatial, and temporal losses of sensitivity in multiple sclerosis.
    Dain SJ; Rammohan KW; Benes SC; King-Smith PE
    Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):548-58. PubMed ID: 2318594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual loss in multiple sclerosis and its relation to previous optic neuritis, disease duration and clinical classification.
    Honan WP; Heron JR; Foster DH; Edgar GK; Scase MO; Collins MF
    Brain; 1990 Aug; 113 ( Pt 4)():975-87. PubMed ID: 2397395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the visual system in multiple sclerosis: a comparative study of diagnostic tests.
    van Diemen HA; Lanting P; Koetsier JC; Strijers RL; van Walbeek HK; Polman CH
    Clin Neurol Neurosurg; 1992; 94(3):191-5. PubMed ID: 1327607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatic spatial contrast sensitivity estimated by visual evoked cortical potential and psychophysics.
    Barboni MT; Gomes BD; Souza GS; Rodrigues AR; Ventura DF; Silveira LC
    Braz J Med Biol Res; 2013 Feb; 46(2):154-63. PubMed ID: 23369980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
    Arch Ophthalmol; 1997 Dec; 115(12):1545-52. PubMed ID: 9400788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis.
    Samsen P; Chuenkongkaew WL; Masayaanon P; Chirapapaisan N; Ruangvaravate N; Loket S
    J Med Assoc Thai; 2007 Feb; 90(2):313-8. PubMed ID: 17375637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of contrast reduction on pattern-reversal VEPs in suspected multiple sclerosis and optic neuritis.
    Davidson AW; Scott RF; Mitchell KW
    Doc Ophthalmol; 2004 Sep; 109(2):157-61. PubMed ID: 15881261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential aging of chromatic and achromatic visual pathways: behavior and electrophysiology.
    Page JW; Crognale MA
    Vision Res; 2005 May; 45(11):1481-9. PubMed ID: 15743617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spatial contrast sensitivity in the differential diagnosis of optic neuritis].
    Karlova IZ; Shamshinova AM; Belozerov AE; Loskutov IA
    Vestn Oftalmol; 1996; 112(3):21-4. PubMed ID: 8966858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatiotemporal contrast sensitivity and colour vision in multiple sclerosis.
    Travis D; Thompson P
    Brain; 1989 Apr; 112 ( Pt 2)():283-303. PubMed ID: 2706434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatio-temporal selectivity of loss of colour and luminance contrast sensitivity with multiple sclerosis and optic neuritis.
    Flanagan P; Markulev C
    Ophthalmic Physiol Opt; 2005 Jan; 25(1):57-65. PubMed ID: 15649184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pattern visual evoked potential. A multicenter study using standardized techniques.
    Brigell M; Kaufman DI; Bobak P; Beydoun A
    Doc Ophthalmol; 1994; 86(1):65-79. PubMed ID: 7956687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.